There were 570 press releases posted in the last 24 hours and 427,987 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image